Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 499

1.

Comparison between Methotrexate and Mycophenolate Mofetil monotherapy for the control of Non- Infectious Ocular Inflammatory Diseases.

Gangaputra SS, Newcomb CW, Joffe MM, Dreger K, Begum H, Artornsombudh P, Pujari SS, Daniel E, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Kempen JH; SITE Cohort Research Group.

Am J Ophthalmol. 2019 Jul 22. pii: S0002-9394(19)30331-9. doi: 10.1016/j.ajo.2019.07.008. [Epub ahead of print]

PMID:
31344346
2.

Remission Of Non-Infectious Anterior Scleritis: Incidence And Predictive Factors.

Kempen JH, Pistilli M, Begum H, Fitzgerald TD, Liesegang TL, Payal A, Zebardast N, Bhatt NP, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE.

Am J Ophthalmol. 2019 Apr 2. pii: S0002-9394(19)30134-5. doi: 10.1016/j.ajo.2019.03.024. [Epub ahead of print]

PMID:
30951689
3.

B Cell Anomalies in Autoimmune Retinopathy (AIR).

Stansky E, Biancotto A, Dagur PK, Gangaputra S, Chaigne-Delalande B, Nussenblatt RB, Sen HN, McCoy JP Jr.

Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3600-3607. doi: 10.1167/iovs.17-21704.

4.

Risk of Ocular Hypertension in Adults with Noninfectious Uveitis.

Daniel E, Pistilli M, Kothari S, Khachatryan N, Kaçmaz RO, Gangaputra SS, Sen HN, Suhler EB, Thorne JE, Foster CS, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Bhatt NP, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Research Group.

Ophthalmology. 2017 Aug;124(8):1196-1208. doi: 10.1016/j.ophtha.2017.03.041. Epub 2017 Apr 19.

5.

Gradient Boosted Decision Tree Classification of Endophthalmitis Versus Uveitis and Lymphoma from Aqueous and Vitreous IL-6 and IL-10 Levels.

Kuo DE, Wei MM, Armbrust KR, Knickelbein JE, Yeung IYL, Nussenblatt RB, Chan CC, Sen HN.

J Ocul Pharmacol Ther. 2017 May;33(4):319-324. doi: 10.1089/jop.2016.0132. Epub 2017 Feb 3.

6.

Panax Notoginseng Saponin Controls IL-17 Expression in Helper T Cells.

Wei JR, Wen X, Bible PW, Li Z, Nussenblatt RB, Wei L.

J Ocul Pharmacol Ther. 2017 May;33(4):285-289. doi: 10.1089/jop.2016.0137. Epub 2017 Jan 4.

7.

Comparative efficacy of steroid-sparing therapies for non-infectious uveitis.

Knickelbein JE, Kim M, Argon E, Nussenblatt RB, Sen NH.

Expert Rev Ophthalmol. 2017;12(4):313-319. doi: 10.1080/17469899.2017.1319762. Epub 2017 Apr 26.

8.

Pharmacologic Treatment of Noninfectious Uveitis.

Knickelbein JE, Armbrust KR, Kim M, Sen HN, Nussenblatt RB.

Handb Exp Pharmacol. 2017;242:231-268. doi: 10.1007/164_2016_21.

PMID:
27848029
9.

DELINEATION OF CHOROIDAL AND RETINAL LESIONS IN POSTERIOR UVEITIS BY MULTISPECTRAL WIDE-FIELD SCANNING LASER OPHTHALMOSCOPY.

Knickelbein JE, Hasan J, Nussenblatt RB, Sen HN.

Retina. 2016 Nov;36(11):2213-2219.

PMID:
27152831
10.

Gevokizumab in the Treatment of Autoimmune Non-necrotizing Anterior Scleritis: Results of a Phase I/II Clinical Trial.

Knickelbein JE, Tucker WR, Bhatt N, Armbrust K, Valent D, Obiyor D, Nussenblatt RB, Sen HN.

Am J Ophthalmol. 2016 Dec;172:104-110. doi: 10.1016/j.ajo.2016.09.017. Epub 2016 Sep 20.

11.

Long-term Management of Panuveitis and Iris Heterochromia in an Ebola Survivor.

Shantha JG, Crozier I, Varkey JB, Kraft CS, Lyon GM 3rd, Mehta AK, Carlson RD, Hill CE, Kumar G, Debiec MR, Patel PS, Olsen TW, Nussenblatt RB, Martin DF, Ströher U, Uyeki TM, Ribner BS, Smith JR, Yeh S.

Ophthalmology. 2016 Dec;123(12):2626-2628.e2. doi: 10.1016/j.ophtha.2016.07.013. Epub 2016 Sep 1. No abstract available.

12.

Reply.

Fox AR, Gordon LK, Heckenlively JR, Davis JL, Goldstein DA, Lowder CY, Nussenblatt RB, Butler NJ, Dalal M, Jayasundera T, Smith WM, Lee RW, Adamus G, Chan CC, Hooks JJ, Morgans CW, Detrick B, Sen HN.

Am J Ophthalmol. 2016 Oct;170:242-243. doi: 10.1016/j.ajo.2016.07.008. Epub 2016 Aug 25. No abstract available.

PMID:
27566926
13.

Modulation of Immune Responses by Extracellular Vesicles From Retinal Pigment Epithelium.

Knickelbein JE, Liu B, Arakelyan A, Zicari S, Hannes S, Chen P, Li Z, Grivel JC, Chaigne-Delalande B, Sen HN, Margolis L, Nussenblatt RB.

Invest Ophthalmol Vis Sci. 2016 Aug 1;57(10):4101-7. doi: 10.1167/iovs.15-18353.

14.

Retinal Pigment Epithelium Tear after Immunosuppressive Treatment for Sarcoidosis-related Choroidal Granuloma.

Knickelbein JE, Wei M, Nussenblatt RB, Sen HN.

Ocul Immunol Inflamm. 2017 Dec;25(6):820-824. doi: 10.1080/09273948.2016.1180402. Epub 2016 Jul 5.

15.

The small tellurium-based compound SAS suppresses inflammation in human retinal pigment epithelium.

Dardik R, Livnat T, Halpert G, Jawad S, Nisgav Y, Azar-Avivi S, Liu B, Nussenblatt RB, Weinberger D, Sredni B.

Mol Vis. 2016 May 28;22:548-62. eCollection 2016.

16.

Ocular Inflammatory Disorders in Autoimmune Lymphoproliferative Syndrome (ALPS).

Ucar D, Kim JS, Bishop RJ, Nussenblatt RB, Rao VK, Sen HN.

Ocul Immunol Inflamm. 2017 Oct;25(5):703-709. doi: 10.1080/09273948.2016.1175637. Epub 2016 May 26.

17.

Consensus on the Diagnosis and Management of Nonparaneoplastic Autoimmune Retinopathy Using a Modified Delphi Approach.

Fox AR, Gordon LK, Heckenlively JR, Davis JL, Goldstein DA, Lowder CY, Nussenblatt RB, Butler NJ, Dalal M, Jayasundera T, Smith WM, Lee RW, Adamus G, Chan CC, Hooks JJ, Morgans CW, Detrick B, Sen HN.

Am J Ophthalmol. 2016 Aug;168:183-190. doi: 10.1016/j.ajo.2016.05.013. Epub 2016 May 20.

18.

Age-related macular degeneration in patients with uveitis.

Fox AR, Chew EY, Meyerle C, Vitale S, Ferris FL, Nussenblatt RB, Sen HN.

Br J Ophthalmol. 2017 Mar;101(3):342-347. doi: 10.1136/bjophthalmol-2016-308587. Epub 2016 May 6.

19.

WALDENSTRÖM'S MACROGLOBULINEMIA MASQUERADING AS BIRDSHOT CHORIORETINOPATHY.

Kim JS, Jaworski L, Patel-Donnelly D, Nussenblatt RB, Sen HN.

Retin Cases Brief Rep. 2017 Spring;11(2):152-155. doi: 10.1097/ICB.0000000000000316.

20.

Ocular Stem Cell Research from Basic Science to Clinical Application: A Report from Zhongshan Ophthalmic Center Ocular Stem Cell Symposium.

Ouyang H, Goldberg JL, Chen S, Li W, Xu GT, Li W, Zhang K, Nussenblatt RB, Liu Y, Xie T, Chan CC, Zack DJ.

Int J Mol Sci. 2016 Mar 22;17(3):415. doi: 10.3390/ijms17030415.

21.

Elevated CD1c+ Myeloid Dendritic Cell Proportions Associate With Clinical Activity and Predict Disease Reactivation in Noninfectious Uveitis.

Chen P, Urzua CA, Knickelbein JE, Kim JS, Li Z, Hannes S, Kuo D, Chaigne-Delalande B, Armbrust K, Tucker W, Liu B, Agrón E, Sen HN, Nussenblatt RB.

Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1765-72. doi: 10.1167/iovs.15-18357.

22.

Adalimumab for Ocular Inflammation.

Durrani K, Kempen JH, Ying GS, Kacmaz RO, Artornsombudh P, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Foster CS Md Facs, Systemic Immunosuppressive Therapy For Eye Diseases Site Research Group.

Ocul Immunol Inflamm. 2017 Jun;25(3):405-412. doi: 10.3109/09273948.2015.1134581. Epub 2016 Mar 22.

23.

Standardizing Flow Cytometry Immunophenotyping Analysis from the Human ImmunoPhenotyping Consortium.

Finak G, Langweiler M, Jaimes M, Malek M, Taghiyar J, Korin Y, Raddassi K, Devine L, Obermoser G, Pekalski ML, Pontikos N, Diaz A, Heck S, Villanova F, Terrazzini N, Kern F, Qian Y, Stanton R, Wang K, Brandes A, Ramey J, Aghaeepour N, Mosmann T, Scheuermann RH, Reed E, Palucka K, Pascual V, Blomberg BB, Nestle F, Nussenblatt RB, Brinkman RR, Gottardo R, Maecker H, McCoy JP.

Sci Rep. 2016 Feb 10;6:20686. doi: 10.1038/srep20686.

24.

Enhanced Depth Imaging Optical Coherence Tomography in Uveitis: An Intravisit and Interobserver Reproducibility Study.

Kim JS, Knickelbein JE, Jaworski L, Kaushal P, Vitale S, Nussenblatt RB, Sen HN.

Am J Ophthalmol. 2016 Apr;164:49-56. doi: 10.1016/j.ajo.2016.01.004. Epub 2016 Jan 29.

25.

Remission of Intermediate Uveitis: Incidence and Predictive Factors.

Kempen JH, Gewaily DY, Newcomb CW, Liesegang TL, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Foster CS, Jabs DA, Payal A, Fitzgerald TD; Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group.

Am J Ophthalmol. 2016 Apr;164:110-7.e2. doi: 10.1016/j.ajo.2015.12.034. Epub 2016 Jan 6.

26.

Memory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic Anemia.

Hosokawa K, Muranski P, Feng X, Townsley DM, Liu B, Knickelbein J, Keyvanfar K, Dumitriu B, Ito S, Kajigaya S, Taylor JG 6th, Kaplan MJ, Nussenblatt RB, Barrett AJ, O'Shea J, Young NS.

J Immunol. 2016 Feb 15;196(4):1568-78. doi: 10.4049/jimmunol.1501739. Epub 2016 Jan 13.

27.

Extracellular HSP60 triggers tissue regeneration and wound healing by regulating inflammation and cell proliferation.

Pei W, Tanaka K, Huang SC, Xu L, Liu B, Sinclair J, Idol J, Varshney GK, Huang H, Lin S, Nussenblatt RB, Mori R, Burgess SM.

NPJ Regen Med. 2016;1. pii: 16013. doi: 10.1038/npjregenmed.2016.13. Epub 2016 Oct 27.

28.

Risk of Retinal Neovascularization in Cases of Uveitis.

Patel AK, Newcomb CW, Liesegang TL, Pujari SS, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Artornsombudh P, Kothari S, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Research Group.

Ophthalmology. 2016 Mar;123(3):646-54. doi: 10.1016/j.ophtha.2015.10.056. Epub 2015 Dec 11.

29.

Biologic Therapies: Anti-Tumor Necrosis Factor-α, Anti-Interleukins, Rituximab and Others.

Bhatt N, Tucker W, Sen HN, Nussenblatt RB.

Dev Ophthalmol. 2016;55:252-64. doi: 10.1159/000431201. Epub 2015 Oct 26. Review.

PMID:
26501216
30.

Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis.

Denniston AK, Holland GN, Kidess A, Nussenblatt RB, Okada AA, Rosenbaum JT, Dick AD.

Orphanet J Rare Dis. 2015 Aug 19;10:97. doi: 10.1186/s13023-015-0318-6. Review.

31.

The Risk of Intraocular Pressure Elevation in Pediatric Noninfectious Uveitis.

Kothari S, Foster CS, Pistilli M, Liesegang TL, Daniel E, Sen HN, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Lawrence SD, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Research Group.

Ophthalmology. 2015 Oct;122(10):1987-2001. doi: 10.1016/j.ophtha.2015.06.041. Epub 2015 Jul 30.

32.

Clinical trials in noninfectious uveitis.

Kim JS, Knickelbein JE, Nussenblatt RB, Sen HN.

Int Ophthalmol Clin. 2015 Summer;55(3):79-110. doi: 10.1097/IIO.0000000000000070. Review. No abstract available.

33.

Inflammatory Mechanisms of Age-related Macular Degeneration.

Knickelbein JE, Chan CC, Sen HN, Ferris FL, Nussenblatt RB.

Int Ophthalmol Clin. 2015 Summer;55(3):63-78. doi: 10.1097/IIO.0000000000000073. Review. No abstract available.

34.

Ocular toxoplasmosis: lessons from Brazil.

Grigg ME, Dubey JP, Nussenblatt RB.

Am J Ophthalmol. 2015 Jun;159(6):999-1001. doi: 10.1016/j.ajo.2015.04.005. No abstract available.

35.

CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses.

Liu B, Dhanda A, Hirani S, Williams EL, Sen HN, Martinez Estrada F, Ling D, Thompson I, Casady M, Li Z, Si H, Tucker W, Wei L, Jawad S, Sura A, Dailey J, Hannes S, Chen P, Chien JL, Gordon S, Lee RW, Nussenblatt RB.

J Immunol. 2015 Jun 1;194(11):5150-60. doi: 10.4049/jimmunol.1402409. Epub 2015 Apr 24.

36.

Increased CD1c+ mDC1 with mature phenotype regulated by TNFα-p38 MAPK in autoimmune ocular inflammatory disease.

Chen P, Denniston A, Hannes S, Tucker W, Wei L, Liu B, Xiao T, Hirani S, Li Z, Jawad S, Si H, Lee RW, Sen HN, Nussenblatt RB.

Clin Immunol. 2015 May;158(1):35-46. doi: 10.1016/j.clim.2015.03.002. Epub 2015 Mar 14.

37.

Glucocorticoid-resistant Th17 cells are selectively attenuated by cyclosporine A.

Schewitz-Bowers LP, Lait PJ, Copland DA, Chen P, Wu W, Dhanda AD, Vistica BP, Williams EL, Liu B, Jawad S, Li Z, Tucker W, Hirani S, Wakabayashi Y, Zhu J, Sen N, Conway-Campbell BL, Gery I, Dick AD, Wei L, Nussenblatt RB, Lee RW.

Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):4080-5. doi: 10.1073/pnas.1418316112. Epub 2015 Mar 16.

38.

Role of dendritic cell subsets in immunity and their contribution to noninfectious uveitis.

Chen P, Denniston AK, Hirani S, Hannes S, Nussenblatt RB.

Surv Ophthalmol. 2015 May-Jun;60(3):242-9. doi: 10.1016/j.survophthal.2015.01.003. Epub 2015 Jan 28. Review.

39.

Levels of blood CD1c+ mDC1 and CD1chi mDC1 subpopulation reflect disease activity in noninfectious uveitis.

Chen P, Tucker W, Hannes S, Liu B, Si H, Gupta A, Lee RW, Sen HN, Nussenblatt RB.

Invest Ophthalmol Vis Sci. 2014 Dec 16;56(1):346-52. doi: 10.1167/iovs.14-15416.

40.

Periocular corticosteroid injections in uveitis: effects and complications.

Sen HN, Vitale S, Gangaputra SS, Nussenblatt RB, Liesegang TL, Levy-Clarke GA, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Kempen JH.

Ophthalmology. 2014 Nov;121(11):2275-86. doi: 10.1016/j.ophtha.2014.05.021. Epub 2014 Jul 11.

41.

Overexpression of IL-17RC associated with ocular sarcoidosis.

Wu W, Jin M, Wang Y, Liu B, Shen D, Chen P, Hannes S, Li Z, Hirani S, Jawad S; UNITE Human Ocular Inflammation Consortium, Sen HN, Chan CC, Nussenblatt RB, Wei L.

J Transl Med. 2014 May 31;12:152. doi: 10.1186/1479-5876-12-152.

42.

Autoimmune and autoinflammatory mechanisms in uveitis.

Lee RW, Nicholson LB, Sen HN, Chan CC, Wei L, Nussenblatt RB, Dick AD.

Semin Immunopathol. 2014 Sep;36(5):581-94. doi: 10.1007/s00281-014-0433-9. Epub 2014 May 24. Review.

43.

Objective measurement of vitreous inflammation using optical coherence tomography.

Keane PA, Karampelas M, Sim DA, Sadda SR, Tufail A, Sen HN, Nussenblatt RB, Dick AD, Lee RW, Murray PI, Pavesio CE, Denniston AK.

Ophthalmology. 2014 Sep;121(9):1706-14. doi: 10.1016/j.ophtha.2014.03.006. Epub 2014 May 15.

44.

Immune responses in age-related macular degeneration and a possible long-term therapeutic strategy for prevention.

Nussenblatt RB, Lee RW, Chew E, Wei L, Liu B, Sen HN, Dick AD, Ferris FL.

Am J Ophthalmol. 2014 Jul;158(1):5-11.e2. doi: 10.1016/j.ajo.2014.03.014. Epub 2014 Apr 4. Review.

45.

Secretion of interleukin-17 by CD8+ T cells expressing CD146 (MCAM).

Dagur PK, Biancotto A, Stansky E, Sen HN, Nussenblatt RB, McCoy JP.

Clin Immunol. 2014 May-Jun;152(1-2):36-47. doi: 10.1016/j.clim.2014.01.009. Epub 2014 Feb 13.

46.

Factors predictive of remission of new-onset anterior uveitis.

Artornsombudh P, Pistilli M, Foster CS, Pujari SS, Gangaputra SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Kempen JH.

Ophthalmology. 2014 Mar;121(3):778-84. doi: 10.1016/j.ophtha.2013.09.041. Epub 2013 Dec 15.

47.

Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema.

Levin MH, Pistilli M, Daniel E, Gangaputra SS, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study.

Ophthalmology. 2014 Feb;121(2):588-95.e1. doi: 10.1016/j.ophtha.2013.09.023. Epub 2013 Dec 12.

48.

Autoimmune retinopathy.

Grange L, Dalal M, Nussenblatt RB, Sen HN.

Am J Ophthalmol. 2014 Feb;157(2):266-272.e1. doi: 10.1016/j.ajo.2013.09.019. Epub 2013 Sep 29. Review.

49.

Neoplastic masquerade syndromes in patients with uveitis.

Grange LK, Kouchouk A, Dalal MD, Vitale S, Nussenblatt RB, Chan CC, Sen HN.

Am J Ophthalmol. 2014 Mar;157(3):526-31. doi: 10.1016/j.ajo.2013.11.002. Epub 2013 Nov 6.

50.

Syphilitic outer retinopathy.

Lima BR, Mandelcorn ED, Bakshi N, Nussenblatt RB, Sen HN.

Ocul Immunol Inflamm. 2014 Feb;22(1):4-8. doi: 10.3109/09273948.2013.841960. Epub 2013 Oct 30.

PMID:
24171649

Supplemental Content

Loading ...
Support Center